BioCryst Pharmaceuticals, Inc. (FRA:BO1)
6.67
+0.06 (0.94%)
At close: Dec 5, 2025
BioCryst Pharmaceuticals Market Cap
BioCryst Pharmaceuticals has a market cap or net worth of €1.37 billion as of December 5, 2025. Its market cap has decreased by -0.71% in one year.
Market Cap
1.37B
Enterprise Value
1.78B
Revenue
511.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.67
Market Cap Chart
Since March 4, 1994, BioCryst Pharmaceuticals's market cap has increased from 19.07M to 1.37B, an increase of 7,101.86%. That is a compound annual growth rate of 14.41%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 98.87B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.10B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |